Jason A Keyes insider trades: BlossomHill Therapeutics (BLSM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jason reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | BLSM | ↑ Buy | 700 | $16.00 | $11K | Direct | Aug 10, 2026 (0d) |
| Jan 23, 2025 | EQ | ↓ Sell | 10,000 | $0.65 | $7K | By The Keyes Trust Dated September 10, 2 | Jan 24, 2025 (1d) |
| Nov 14, 2024 | EQ | ↓ Sell | 10,000 | $0.70 | $7K | By The Keyes Trust Dated September 10, 2 | Nov 15, 2024 (1d) |
| Sep 26, 2024 | EQ | ↓ Sell | 10,000 | $0.81 | $8K | By The Keyes Trust Dated September 10, 2 | Sep 27, 2024 (1d) |
| Jul 16, 2024 | EQ | ↓ Sell | 10,000 | $0.87 | $9K | By The Keyes Trust Dated September 10, 2 | Jul 18, 2024 (2d) |
| Aug 29, 2022 | EQ | ↓ Sell | 7,000 | $2.83 | $20K | By The Keyes Trust Dated September 10, 2 | Aug 30, 2022 (1d) |
| Jun 6, 2022 | EQ | ↓ Sell | 5,000 | $2.52 | $13K | By The Keyes Trust Dated September 10, 2 | Jun 6, 2022 (0d) |
| Apr 4, 2022 | EQ | ↓ Sell | 8,000 | $3.18 | $25K | By The Keyes Trust Dated September 10, 2 | Apr 5, 2022 (1d) |
| Dec 1, 2021 | EQ | ↓ Sell10b5-1 | 5,000 | $5.08 | $25K | By The Keyes Trust Dated September 10, 2 | Dec 3, 2021 (2d) |
| Sep 27, 2021 | EQ | ↓ Sell10b5-1 | 8,000 | $6.74 | $54K | By The Keyes Trust Dated September 10, 2 | Sep 29, 2021 (2d) |
| Jul 27, 2021 | EQ | ↓ Sell10b5-1 | 5,000 | $5.72 | $29K | By The Keyes Trust Dated September 10, 2 | Jul 28, 2021 (1d) |
| May 26, 2021 | EQ | ↓ Sell10b5-1 | 5,000 | $6.50 | $32K | By The Keyes Trust Dated September 10, 2 | May 28, 2021 (2d) |
| Dec 23, 2020 | EQ | ↓ Sell | 8,000 | $4.74 | $38K | By The Keyes Trust Dated September 10, 2 | Dec 28, 2020 (5d) |
| Feb 18, 2020 | EQ | ↓ Sell | 5,000 | $5.03 | $25K | By The Keyes Trust Dated September 10, 2 | Feb 19, 2020 (1d) |
| Jan 21, 2020 | EQ | ↓ Sell | 5,000 | $4.41 | $22K | By The Keyes Trust Dated September 10, 2 | Jan 22, 2020 (1d) |
| Sep 3, 2019 | EQ | ↓ Sell | 5,000 | $3.60 | $18K | By The Keyes Trust Dated September 10, 2 | Sep 4, 2019 (1d) |
| Aug 1, 2019 | EQ | ↓ Sell | 5,000 | $3.99 | $20K | By The Keyes Trust Dated September 10, 2 | Aug 5, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BLSM insiders
Open-market trades in the last 12 months
About Jason A Keyes's insider trades
Jason A Keyes is Chief Financial Officer at BlossomHill Therapeutics (BLSM). Since Aug 1, 2019, Jason has reported 1 open-market purchase worth $11K and 16 sales worth $352K on SEC Form 4. In the last 12 months: 1 buy ($11K).
4 sales (40% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (24 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLSM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.